Ligand Pharmaceuticals Ratios (2010-2025) | LGND

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2010	Sep2010	Dec2010	Mar2011	Jun2011	Sep2011	Dec2011	Mar2012	Jun2012	Sep2012	Dec2012	Mar2013	Jun2013	Sep2013	Dec2013	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Profitability
Gross Margin				86.52%	78.25%	87.75%	84.09%	97.25%	92.42%	89.29%	82.93%	94.31%	87.33%	80.48%	91.07%	84.64%	88.82%	90.01%	82.59%	92.64%	85.88%	92.94%	95.83%	96.78%	96.31%	95.38%	92.41%	99.39%	99.00%	94.78%	97.08%	98.60%	98.74%	96.80%	95.04%	91.13%	90.37%	87.31%	92.83%	85.88%	81.55%	84.82%	83.23%	82.50%	61.20%	80.83%	78.75%	87.13%	75.34%	76.10%	57.10%	91.55%	93.67%	89.40%	94.16%	90.70%	93.00%	95.27%	93.37%	89.30%	93.90%	96.71%
EBT Margin	-45.59%	-146.58%	-40.28%	-105.47%	-10.36%	-72.39%	38.56%	-13.72%	-69.49%	-0.82%	6.97%	11.76%	39.71%	15.57%	13.61%	13.47%	11.70%	6.02%	30.48%	-0.51%	121.03%	41.15%	27.50%	32.28%	-51.49%	5.60%	18.93%	11.03%	9.22%	26.43%	51.46%	98.50%	106.15%	173.50%	-95.30%	1,937.98%	-72.15%	-80.10%	-30.27%	-91.72%	67.89%	-27.75%	21.72%	12.37%	42.23%	25.56%	31.70%	-25.04%	17.28%	20.86%	47.91%	126.28%	12.03%	-36.95%	60.84%	366.22%	-157.45%	-12.23%	-91.56%	-110.69%	23.56%	122.24%
EBIT Margin	-67.57%	-200.91%	-151.32%	-38.06%	-10.85%	-56.59%	36.04%	-14.89%	-31.61%	-22.35%	31.34%	33.75%	15.80%	23.61%	43.60%	31.96%	12.80%	23.59%	41.90%	22.94%	23.70%	48.57%	51.98%	50.92%	20.33%	25.28%	50.69%	18.19%	14.45%	36.12%	47.58%	65.96%	77.93%	51.16%	55.63%	1,900.80%	-16.53%	-20.79%	-37.70%	11.42%	17.14%	8.95%	32.67%	10.12%	58.00%	26.31%	66.82%	5.84%	17.28%	20.84%	-39.89%	32.30%	-7.52%	9.36%	-11.95%	9.65%	-45.99%	6.07%	-22.51%	-79.89%	17.73%	47.58%
EBITDA Margin	-67.57%	-200.91%	-151.32%	246.38%	-10.85%	-56.59%	36.04%	20.10%	-31.61%	-22.35%	31.34%	33.75%	15.80%	23.61%	43.60%	31.96%	12.80%	23.59%	41.90%	22.94%	23.70%	48.57%	51.98%	50.92%	20.33%	25.28%	50.69%	18.19%	14.45%	36.12%	47.58%	65.96%	77.93%	51.16%	55.63%	1,900.80%	-16.53%	-20.79%	-37.70%	11.42%	17.14%	8.95%	32.67%	10.12%	58.00%	26.31%	66.82%	5.84%	17.28%	20.84%	-39.89%	32.30%	-7.52%	9.36%	-11.95%	9.65%	-45.99%	6.07%	-22.51%	-79.89%	17.73%	47.58%
Operating Margin	-67.57%	-200.91%	-151.32%	-38.06%	-10.85%	-56.59%	36.04%	-14.89%	-31.61%	-22.35%	31.34%	33.75%	15.80%	23.61%	43.60%	31.96%	12.80%	23.59%	41.90%	22.94%	23.70%	48.57%	51.98%	50.92%	20.33%	25.28%	50.69%	18.19%	14.45%	36.12%	47.58%	65.96%	77.93%	51.16%	55.63%	1,900.80%	-16.53%	-20.79%	-37.70%	11.42%	17.14%	8.95%	32.67%	10.12%	58.00%	26.31%	66.82%	5.84%	17.28%	20.84%	-39.89%	32.30%	-7.52%	9.36%	-11.95%	9.65%	-45.99%	6.07%	-22.51%	-79.89%	17.73%	47.58%
Net Margin	4.01%	0.15%	54.70%	0.10%	-12.25%	-0.02%	36.26%	33.20%	31.33%	-3.04%	-11.17%	1.64%	25.02%	15.11%	12.68%	13.14%	22.36%	15.80%	37.57%	18.24%	119.59%	1,125.16%	29.92%	2.47%	-31.61%	4.86%	-8.18%	-6.84%	-15.68%	0.45%	75.47%	80.63%	81.25%	147.52%	-71.29%	1,532.37%	-57.71%	-61.48%	-27.27%	-72.77%	53.32%	-16.01%	25.13%	-10.00%	-7.25%	-11.08%	-3.94%	-6.73%	-26.92%	-15.60%	-5.86%	-3.79%	8.69%	-31.26%	64.72%	278.07%	-124.99%	-13.84%	-72.62%	-93.64%	10.18%	101.57%
FCF Margin		-98.41%	-32.44%	23.25%	-107.80%	-20.31%	54.53%	-6.88%	-16.96%	-20.11%	22.81%	23.03%	72.83%	-4.81%	80.88%	16.11%	39.02%	24.94%	43.98%	51.84%	54.45%	58.96%	64.17%	43.43%	49.12%	82.15%	48.86%	34.08%	11.63%	56.83%	51.78%	108.20%	81.71%	59.44%	53.18%	103.39%	19.40%	-24.76%	-36.63%	50.84%	57.11%	25.59%	-1.56%	15.78%	24.08%	30.58%	45.12%	129.08%	10.55%	27.29%	101.90%	71.70%	-1.08%	21.78%	27.22%	60.13%	-148.28%	70.50%	237.43%	-56.60%	32.72%	11.32%
Efficiency
Inventory Average						2.28M	1.63M	1.32M			2.12M	2.27M	2.55M	2.05M	1.61M	1.67M	1.38M	0.94M	0.67M	1.54M	1.81M	1.01M	1.43M	1.69M	2.79M	3.93M	2.98M	4.78M	7.22M	5.91M	4.69M	7.45M	10.03M	8.83M	7.63M	9.51M	10.77M	8.10M	6.93M	7.31M	5.51M	8.57M	19.96M	31.71M	38.44M	36.47M	30.16M	26.47M	25.19M	23.55M	17.81M	13.65M	20.46M	26.15M	24.68M	22.65M	20.00M	17.71M	15.43M	14.36M	15.05M	13.69M
Assets Average						125.57M	121.87M	116.19M			100.88M	101.31M	98.97M	100.62M	103.19M	105.09M	102.66M	186.06M	265.16M	260.63M	283.99M	400.54M	499.69M	544.51M	587.64M	595.09M	601.23M	615.65M	634.87M	651.18M	666.68M	712.84M	1,306.48M	1,982.01M	1,683.27M	1,587.40M	1,857.91M	1,674.66M	1,521.20M	1,340.42M	1,214.43M	1,245.19M	1,304.87M	1,328.70M	1,275.70M	1,264.97M	1,285.62M	1,201.39M	1,090.74M	1,063.45M	906.64M	786.87M	784.59M	763.67M	778.22M	850.54M	890.14M	910.64M	948.32M	923.60M	927.02M	1,212.69M
Equity Average						4.46M	5.62M				23.86M	28.54M	34.93M	42.04M	47.21M	57.31M	64.59M	54.27M	35.34M	30.73M	52.10M	167.93M	252.04M	300.94M	347.18M	334.01M	339.77M	356.56M	378.47M	394.14M	401.48M	440.44M	550.46M	659.67M	630.22M	820.44M	1,060.71M	946.02M	808.91M	714.56M	678.45M	696.41M	703.67M	727.68M	766.18M	799.29M	816.61M	807.18M	797.78M	809.33M	706.89M	621.90M	655.60M	666.39M	684.40M	753.72M	790.86M	808.19M	835.81M	812.99M	812.03M	889.35M
Invested Capital			-4.85M		15.87M	13.06M	18.18M	1.50M		21.23M	26.48M	30.60M	39.27M	44.81M	49.61M	65.00M	64.17M	44.37M	271.32M	35.15M	69.05M	266.81M	482.28M	609.60M	574.76M	548.37M	554.20M	587.58M	603.75M	624.72M	624.32M	708.65M	1,021.10M	1,262.68M	587.35M	1,106.73M	1,068.54M	850.58M	767.23M	661.90M	695.00M	697.82M	716.23M	745.84M	786.52M	812.07M	821.26M	793.19M	917.34M	892.90M	597.53M	723.11M	664.89M	667.90M	700.94M	806.52M	775.20M	841.18M	830.51M	795.53M	828.53M	950.17M
Asset Utilization Ratio						0.17	0.25	0.27			0.31	0.37	0.42	0.48	0.47	0.51	0.53	0.30	0.24	0.24	0.25	0.18	0.14	0.16	0.15	0.15	0.18	0.22	0.32	0.35	0.38	0.35	0.19	0.13	0.15	0.15	0.09	0.09	0.08	0.08	0.10	0.12	0.14	0.15	0.19	0.20	0.19	0.19	0.19	0.19	0.22	0.26	0.23	0.20	0.17	0.14	0.15	0.17	0.18	0.20	0.20	0.21
Leverage & Solvency
Interest Coverage Ratio	-223.67	-0.00M	-313.79	-3.51	-1.20	-4.65	6.25	-1.20	-2.38	-1.94		4.31	3.34	7.79		20.56	7.50	2.33		1.13	1.47	2.93		5.02	1.30	1.75	5.27	3.47	3.90	4.87	8.26	10.64	5.22	2.09	1.65	92.81	-0.46	-0.57	-1.15	0.44	1.14	0.60	3.58	0.81	9.37	3.54	8.44	2.70	19.78	37.17	-83.75	59.19	-6.98	0.00M	-25.63	21.19	-15.06	4.24	-10.91	-41.77	7.32	60.36
Debt to Equity					5.13	9.87	3.70			0.84	0.51	0.18	0.05						7.44				1.72		0.63	0.62	0.62	0.58	0.57	0.55	0.56	0.47	0.65	0.81	0.05	0.02	0.03												0.14	0.09	0.13	0.12										0.47
Debt Ratio					0.24	0.25	0.25	0.25		0.18	0.13	0.06	0.02						0.76				0.81		0.35	0.35	0.35	0.34	0.34	0.33	0.33	0.30	0.22	0.27	0.02	0.01	0.02												0.11	0.07	0.10	0.09										0.30
Equity Ratio			-0.06		0.05	0.02	0.07			0.22	0.25	0.31	0.39	0.44	0.47	0.62	0.64	0.16	0.10	0.13	0.23	0.54	0.47	0.62	0.56	0.56	0.57	0.59	0.60	0.61	0.60	0.64	0.33	0.33	0.44	0.56	0.58	0.55	0.51	0.56	0.56	0.56	0.52	0.58	0.63	0.64	0.63	0.72	0.75	0.78	0.78	0.80	0.88	0.87	0.89	0.88	0.89	0.88	0.88	0.88	0.87	0.64
Times Interest Earned	-223.67	-0.00M	-313.79	-3.51	-1.20	-4.65	6.25	-1.20	-2.38	-1.94		4.31	3.34	7.79		20.56	7.50	2.33		1.13	1.47	2.93		5.02	1.30	1.75	5.27	3.47	3.90	4.87	8.26	10.64	5.22	2.09	1.65	92.81	-0.46	-0.57	-1.15	0.44	1.14	0.60	3.58	0.81	9.37	3.54	8.44	2.70	19.78	37.17	-83.75	59.19	-6.98	0.00M	-25.63	21.19	-15.06	4.24	-10.91	-41.77	7.32	60.36
Valuation
Enterprise Value	168.43M	192.73M	160.57M	190.18M	229.58M	265.22M	224.83M	302.65M	325.42M	334.87M	401.68M	533.51M	750.86M	881.41M	1,057.60M	1,361.49M	1,267.87M	788.31M	896.19M	1,329.65M	1,802.77M	1,513.27M	1,960.13M	2,111.39M	2,376.54M	2,004.28M	1,982.62M	2,054.79M	2,376.29M	2,664.17M	2,699.63M	3,237.74M	3,456.08M	4,786.11M	2,165.75M	1,141.50M	905.11M	792.72M	761.82M	461.45M	985.28M	737.50M	1,189.10M	2,193.36M	1,882.75M	2,000.16M	2,240.17M	1,691.76M	1,356.43M	1,332.37M	916.62M	973.49M	1,026.31M	849.42M	1,074.97M	983.66M	1,286.69M	1,608.90M	1,768.47M	1,815.61M	1,948.34M	2,806.81M
Market Capitalization	171.67M	196.53M	174.92M	196.21M	234.68M	269.13M	233.53M	313.95M	334.30M	341.92M	414.06M	538.55M	756.79M	884.68M	1,073.58M	1,386.74M	1,290.98M	976.49M	1,065.43M	1,509.63M	1,984.37M	1,700.57M	2,160.35M	2,224.59M	2,483.49M	2,128.40M	2,123.67M	2,214.16M	2,548.92M	2,866.43M	2,889.97M	3,502.10M	4,413.01M	5,792.79M	2,884.13M	2,570.19M	2,237.16M	1,892.40M	1,831.69M	1,200.26M	1,795.16M	1,532.57M	1,600.28M	2,532.56M	2,184.59M	2,323.37M	2,581.28M	1,895.75M	1,504.37M	1,453.77M	1,128.49M	1,256.16M	1,245.35M	1,039.93M	1,245.28M	1,294.26M	1,513.62M	1,828.54M	2,024.64M	2,024.51M	2,193.36M	3,471.33M
Return Ratios
Return on Sales				0.11%	0.05%	0.06%	0.13%	0.18%	0.28%	0.27%	0.06%	0.01%	0.02%	0.06%	0.13%	0.16%	0.13%	0.11%	0.17%	0.14%	0.41%	3.09%	3.16%	2.62%	2.27%	0.02%	-0.07%	-0.09%	-0.10%	-0.09%	0.11%	0.30%	0.65%	0.92%	0.57%	3.20%	3.90%	3.89%	5.23%	-0.56%	-0.20%	-0.11%	0.05%	0.14%	0.00%	0.00%	-0.08%	-0.07%	-0.12%	-0.14%	-0.14%	-0.13%	-0.06%	-0.08%	0.07%	0.81%	0.32%	0.30%	-0.02%	-0.73%	-0.40%	0.19%
Return on Capital Employed						-0.14%	-0.01%	0.00%			0.00%	0.07%	0.12%	0.19%	0.20%	0.19%	0.19%	0.10%	0.08%	0.07%	0.08%	0.07%	0.10%	0.07%	0.11%	0.10%	0.12%	0.10%	0.12%	0.14%	0.16%	0.20%	0.23%	0.13%	0.10%	0.68%	0.50%	0.52%	0.54%	-0.01%	0.00%	0.00%	0.03%	0.03%	0.06%	0.07%	0.08%	0.09%	0.07%	0.07%	0.00%	0.02%	0.01%	-0.01%	0.02%	0.00%	-0.02%	-0.02%	-0.02%	-0.07%	-0.04%	0.01%
Return on Invested Capital											0.01%	0.06%			0.30%	0.27%	0.24%	0.29%	0.12%	0.11%	0.39%										0.05%	0.10%	0.15%	0.12%	0.15%	0.90%	0.65%	0.70%	0.79%	-0.02%	-0.01%	0.00%						0.10%	0.06%	0.05%		0.01%	0.00%	0.00%	0.01%	0.00%	-0.02%	-0.02%		-0.06%	-0.04%	0.02%
Return on Assets						0.01%	0.03%	0.05%			0.02%	0.00%	0.01%	0.03%	0.06%	0.08%	0.07%	0.03%	0.04%	0.03%	0.10%	0.57%	0.46%	0.42%	0.34%	0.00%	-0.01%	-0.02%	-0.03%	-0.03%	0.04%	0.11%	0.13%	0.12%	0.09%	0.48%	0.36%	0.35%	0.41%	-0.05%	-0.02%	-0.01%	0.01%	0.02%	0.00%	0.00%	-0.01%	-0.01%	-0.02%	-0.03%	-0.03%	-0.03%	-0.01%	-0.02%	0.01%	0.11%	0.05%	0.05%	0.00%	-0.14%	-0.08%	0.04%
Return on Equity						0.28%	0.67%				0.08%	0.01%	0.02%	0.07%	0.14%	0.15%	0.11%	0.11%	0.31%	0.28%	0.57%	1.36%	0.90%	0.76%	0.58%	0.01%	-0.02%	-0.03%	-0.05%	-0.05%	0.07%	0.17%	0.30%	0.35%	0.23%	0.93%	0.64%	0.63%	0.78%	-0.09%	-0.04%	-0.02%	0.01%	0.04%	0.00%	0.00%	-0.02%	-0.02%	-0.03%	-0.03%	-0.04%	-0.04%	-0.02%	-0.02%	0.01%	0.13%	0.05%	0.06%	0.00%	-0.16%	-0.09%	0.05%

Research Tools

Ligand Pharmaceuticals Ratios (2010-2025) | LGND

Create an account

Sign In

Reset Password

Get Pro for 60% off